Trecondi
Trecondi Uses, Dosage, Side Effects, Food Interaction and all others data.
Trecondi is under investigation in Allogeneic Haematopoietic Stem Cell Transplantation. Trecondi has been investigated for the treatment of Lymphoblastic Leukemia, Acute, Childhood.
Trade Name | Trecondi |
Generic | Treosulfan |
Treosulfan Other Names | DIHYDROXYBUSULFAN, OVASTAT, Treosulfan |
Type | infusion |
Formula | C6H14O8S2 |
Weight | Average: 278.29 Monoisotopic: 278.013009759 |
Groups | Approved, Investigational |
Therapeutic Class | |
Manufacturer | medac GmbH |
Available Country | United Kingdom |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Trecondi